Search

everythinglearnresearchcommunity

for

Search:↓

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

JAK-inhibitors are effective for treating psoriasis and show promise for other skin diseases.

Adalimumab was safe but mostly ineffective for severe alopecia areata.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

TNF-alpha inhibitors can cause various immune-related skin issues.

Tildrakizumab significantly improved psoriasis symptoms and well-being over 52 weeks.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

QR678 Neo® improved seborrheic dermatitis symptoms in a small group of patients.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Selencin effectively reduces hair loss and improves hair health in diffuse alopecia.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Adalimumab helped control a child's severe eye disease when other treatments failed.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

SB414 may be an effective treatment for atopic dermatitis by reducing swelling and bacterial infection.

Brodalumab is more effective than ustekinumab in treating psoriasis.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Dupilumab effectively reduces alopecia areata symptoms in children with atopic dermatitis.

Ruxolitinib can cause a delayed skin reaction on the nose.

Dupilumab can cause psoriasis in some patients.

Acitretin is effective for certain types of psoriasis, safe for long-term use, and often combined with other treatments.

Adipose stem cell exosomes can effectively reduce facial redness and improve skin health in atopic dermatitis patients.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Mogamulizumab treatment in Sézary syndrome may cause skin issues and hair loss but can lead to a complete response.

JAK/STAT inhibitors show promise for skin diseases but aren't yet approved.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.